StockTipsArenaBeta

BUY Concord Biotech Limited — IDBI Capital

BUYConcord Biotech Limited
Concord Biotech share price target & all analyst calls

byIDBI CapitalHorizon: NA (inferred 1–3 months)21 Sept 2026via IDBI Capital Research Calls Telegram

Entry₹1,546Stated
Target₹1,685
Total upside +8.99% (call closed)
Stop loss₹1,475-4.59% risk
Exit₹1,47524 Sept 2026, 12:09 pm
Stop-loss hit-4.59%
Follow IDBI Capital for new calls(32% target hit, 206 closed calls)Get alertsWatch CONCORDBIO for new buy/sell callsGet alertsSee 74 active Short-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 24 Sept 2026
7 supporting0 opposing
Supports the BUY call (7)

Concord Biotech announces 1:1 bonus share issue; shareholders to get one free share for each held

NewsCnbc-Tv18·23 Sept · today

(opens in new tab)

Concord Biotech 1:1 bonus issue: Jhunjhunwala family-backed pharma stock gains 50% in 6 months, check record date detail

NewsLivemint·23 Sept · today

(opens in new tab)

Concord Biotech Ltd's Board approved the issuance of Bonus shares and an increase in Authorised Share Capital during their meeting on September 23, 2026.

BSE · Board Meeting·23 Sept · today

(opens in new tab)

Concord Biotech bonus issue sparks rally! Pharma stock jumps 6% on maiden share reward - Top things to know

NewsLivemint·21 Sept · 2d ago

(opens in new tab)

Bonus Alert: Stock with significant Jhunjhunwala family stake set to reward shareholders

NewsCnbc-Tv18·21 Sept · 3d ago

(opens in new tab)
Neutral / worth noting (0)

Nothing found in this tip’s window yet.

Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Concord Biotech

All analyst calls on Concord Biotech

More from IDBI Capital

Every call and its outcome